KORU Medical Systems, Inc. KRMD
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -48.54%
- 1 year
- -23.33%
- Open
- 3.24
- Prev close
- 3.23
- Mkt cap
- 137.34M
- Vol
- 165.22K
- Avg vol
- 241.79K
- EPS
- -0.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.99
- High
- 3.25
- Forward P/E
- -43.89
- Beta
- 0.41
- Short ratio
- 11.67
- Inst. own
- 54.38%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 3.27
- 200-d avg
- 2.59
- 1y target
- 4.90
1M chart
Signals (9)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bearish | Oct 30, 2026 | 2 days ago |
| SMA: Bullish | Oct 27, 2026 | 5 days ago |
| SMA: Bearish | Oct 26, 2026 | 6 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 19, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 12, 2026 | 2 weeks ago |
Key statistics
- Market cap
- 181.06M
- Enterprise value
- 134.74M
- Trailing P/E
- 0.00
- Forward P/E
- -43.89
- PEG ratio
- 0.00
- Price / sales
- 5.88
- Price / book
- 8.86
- EPS (TTM)
- -0.26
- Beta
- 0.41
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -38.16%
- Revenue (TTM)
- 30.82M
- Revenue growth
- 21.50%
- Free cash flow
- 1.05M
- Total cash
- 10.46M
- Total debt
- 3.97M
- Return on equity
- -50.25%
- Shares outstanding
- 45.84M
- Short % of float
- 2.06%
- 50-day average
- 3.27
- 200-day average
- 2.59
Analyst view
Consensus: strong buy
- Target (low)
- 3.50
- Target (mean)
- 4.90
- Target (high)
- 7.00
- Strong buy1
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.0325.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.03 | -0.03 | 0.00 | 0.00% |
| Aug 7, 2024 | Jun 1, 2024 | -0.04 | -0.02 | +0.02 | +50.00% |
| May 1, 2024 | Mar 1, 2024 | -0.04 | -0.02 | +0.02 | +50.00% |
| Mar 13, 2024 | Dec 1, 2023 | -0.04 | -0.02 | +0.02 | +50.00% |
| Nov 8, 2023 | Sep 1, 2023 | -0.04 | -0.03 | +0.01 | +25.00% |
| Aug 9, 2023 | Jun 1, 2023 | -0.05 | -0.05 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | Craig-Hallum | main | Buy | Buy |
| Nov 14, 2024 | Canaccord Genuity | main | Buy | Buy |
| Nov 14, 2024 | Piper Sandler | main | Overweight | Overweight |
| Aug 8, 2024 | Piper Sandler | main | Overweight | Overweight |
| Mar 14, 2024 | B. Riley Securities | reit | Buy | Buy |
| Dec 7, 2023 | Canaccord Genuity | reit | Buy | Buy |
About KORU Medical Systems, Inc.
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- korumedical.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on KRMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BECK JAMES M. | Director | Stock Award(Grant) | Jun 29, 2023 | 90,284 |
| CASCELLA ROBERT A | Director | Stock Award(Grant) | Sep 30, 2024 | 70,978 |
| FLETCHER R JOHN | Chairman of the Board | Stock Award(Grant) | Sep 30, 2024 | 190,851 |
| FRENCH DONNA | Director | Stock Award(Grant) | Sep 30, 2024 | 70,978 |
| MANKO JOSEPH M JR | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Sep 29, 2024 | 0 |
| MATIN SHAHRIAR | Director | Stock Award(Grant) | Sep 30, 2024 | 73,608 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| First Light Asset Management, LLC | 14.04% | 5,598,925 | 22.12M | Sep 29, 2024 |
| Vanguard Group Inc | 4.47% | 1,782,801 | 7.04M | Sep 29, 2024 |
| Meros Investment Management, Lp | 2.02% | 805,384 | 3.18M | Sep 29, 2024 |
| Albion Financial Group | 1.67% | 667,783 | 2.64M | Sep 29, 2024 |
| RBF Capital, LLC | 1.31% | 521,319 | 2.06M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.16% | 462,128 | 1.83M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.86% | 1,140,651 | 4.51M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.45% | 579,541 | 2.29M | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.62% | 245,888 | 971.26K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 85,301 | 336.94K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.18% | 73,136 | 288.89K | Oct 30, 2024 |
| Forum Funds II-Acuitas U.S. Micro Cap Fund | 0.17% | 68,232 | 269.52K | Sep 29, 2024 |